Therefore, this study aims to evaluate the expression of PD-1, TIGIT, LAG-3, Tim-3, BTLA, and NKG2A in CD8+ T cells from women with cervical cancer, both before and after treatment, in order to better understand their role in T cell dysfunction and identify potential targets for future therapeutic strategies. This evidence concerns the gene LAG3 and cervical carcinoma.